292
Participants
Start Date
November 30, 2013
Primary Completion Date
September 30, 2014
Study Completion Date
April 30, 2015
SP-333 1 mg
Tablet
SP-333 3 mg
Tablet
SP-333 6 mg
Tablet
Placebo
Tablet
Synergy Research Site, New York
Synergy Research Site, Great Neck
Synergy Research Site, Winston-Salem
Synergy Research Site, Greensboro
Synergy Research Site, Concord
Synergy Research Site, Salisbury
Synergy Research Site, Orangeburg
Synergy Research Site, Atlanta
Synergy Research Site, Port Orange
Synergy Research Site, Hialeah
Synergy Research Site, Miami Beach
Synergy Research Site, Miami
Synergy Research Site, Plantation
Synergy Research Site, West Palm Beach
Synergy Research Site, Plant City
Synergy Research Site, Winter Haven
Synergy Research Site, Sarasota
Synergy Research Site, Huntsville
Synergy Research Site, Mobile
Synergy Research Site, Chattanooga
Synergy Research Site, Dayton
Synergy Research Site, Traverse City
Synergy Research Site, Bloomington
Synergy Research Site, St Louis
Synergy Research Site, Oklahoma City
Synergy Research Site, Oklahoma City
Synergy Research Site, Oklahoma City
Synergy Research Site, Dallas
Synergy Research Site, Dallas
Synergy Research Site, Arlington
Synergy Research Site, Houston
Synergy Research Site, San Antonio
Synergy Research Site, Phoenix
Synergy Research Site, Las Vegas
Synergy Research Site, Artesia
Synergy Research Site, Oceanside
Synergy Research Site, San Diego
Synergy Research Site, San Diego
Synergy Research Site, Laguna Hills
Synergy Research Site, San Francisco
Synergy Research Site, Sacramento
Synergy Research Site, Medford
Bausch Health Americas, Inc.
INDUSTRY